Terms: = Sarcomas AND ERC1, ELKS, 23085, ENSG00000082805, MGC12974, RAB6IP2, KIAA1081, Cast2, Q8IUD2, KIAA108
2 results:
1. Successful Crizotinib-targeted Therapy of Pediatric Unresectable erc1::ALK Fusion Sarcoma.
Wood ML; Fanburg-Smith JC; Brian JM; White JC; Powell JL; Freiberg AS
J Pediatr Hematol Oncol; 2024 Mar; 46(2):e184-e187. PubMed ID: 38099690
[TBL] [Abstract] [Full Text] [Related]
2. Novel fusion sarcomas including targetable NTRK and ALK.
Chen T; Wang Y; Goetz L; Corey Z; Dougher MC; Smith JD; Fox EJ; Freiberg AS; Flemming D; Fanburg-Smith JC
Ann Diagn Pathol; 2021 Oct; 54():151800. PubMed ID: 34464935
[TBL] [Abstract] [Full Text] [Related]